Skip to main content

Table 1 General characteristics of DGKζ-TG and WT mice at 8 weeks after STZ injection.

From: Diacylglycerol kinase ζ inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus

  WT control DGKζ-TG control WT STZ DGKζ-TG STZ
BW, g 32.08 ± 0.70 32.3 ± 0.65 22.37 ± 0.91* 22.8 ± 0.54§
BG, mg/dl 155.4 ± 0.47 157.7 ± 0.54 465.8 ± 0.61* 455.3 ± 0.53§
HW, mg 147 ± 0.02 142 ± 0.01 92 ± 0.02* 110 ± 0.02§ddag
LVW, mg 107 ± 0.01 105 ± 0.01 69 ± 0.01* 77 ± 0.01§
HW/BW ratio, mg/g 4.58 ± 0.13 4.41 ± 0.08 4.00 ± 0.14* 4.44 ± 0.12‡
LVW/BW ratio, mg/g 3.32 ± 0.07 3.24 ± 0.05 3.0 ± 0.09* 3.25 ± 0.08‡
  1. Data are mean ± SEM from 15 mice for each group. BW, body weight; BG, blood glucose; HW, heart weight; LVW, left ventricular weight. *P < 0.01 vs. WT control, ‡P < 0.05 vs. WT STZ, §P < 0.01 vs. DGKζ-TG control.